Radiotherapy plus cetuximab or cisplatin in human papillomavirus-positive oropharyngeal cancer (NRG Oncology RTOG 1016): a randomised, multicentre, non-inferiority trial. - Gillison, Maura L.; Ringash, Jolie; Galvin, James; Min Yao; Koyfman, Shlomo A.; Blakaj, Dukagjin M.; Razaq, Mohammed A.; Colevas, A. Dimitrios; Quynh Thu Le; Beitler, Jonathan J.; Jones, Christopher U.; Dunlap, Neal E.; et al. (Lancet, 2019)